Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/13/202412:11PMEdgar (US Regulatory)Form ABS-15G/A - Asset-backed securitizer report pursuant to Section 15G: [Amend]USOTC:FNMFOFederal National Mortgage Association (PK)
05/13/202412:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LOPEGrand Canyon Education Inc
05/13/202412:11PMGlobeNewswire Inc.Transaction in Own SharesEU:SHELLShell Plc
05/13/202412:11PMPR Newswire (Canada)Autoroute 40 (Métropolitaine) en direction ouest : un secteur à éviter du 17 au 21 mai 2024
05/13/202412:11PMGlobeNewswire Inc.Transaction in Own SharesTG:R6C0Shell Plc
05/13/202412:11PMGlobeNewswire Inc.Transaction in Own SharesLSE:SHELShell Plc
05/13/202412:11PMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - LI.WTTSXV:LIAmerican Lithium Corp
05/13/202412:11PMGlobeNewswire Inc.Transaction in Own SharesEU:SHELLShell Plc
05/13/202412:11PMGlobeNewswire Inc.Transaction in Own SharesLSE:SHELShell Plc
05/13/202412:11PMGlobeNewswire Inc.Transaction in Own SharesNYSE:SHELShell plc
05/13/202412:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AAONAAON Inc
05/13/202412:10PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:PLMIWPlum Acquisition Corporation I
05/13/202412:10PMGlobeNewswire Inc.Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés FinanciersTG:SDRCScor SE
05/13/202412:10PMGlobeNewswire Inc.Déclaration au titre de l’article L. 233-8 II du Code de Commerce et de l’article 223-16 du Règlement général de l’Autorité des marchés financiersEU:SCRScor SE
05/13/202412:10PMGlobeNewswire Inc.Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés FinanciersEU:SCRScor SE
05/13/202412:10PMGlobeNewswire Inc.Déclaration au titre de l’article L. 233-8 II du Code de Commerce et de l’article 223-16 du Règlement général de l’Autorité des marchés financiersTG:SDRCScor SE
05/13/202412:10PMEdgar (US Regulatory)Form ABS-15G/A - Asset-backed securitizer report pursuant to Section 15G: [Amend]USOTC:FNMFOFederal National Mortgage Association (PK)
05/13/202412:10PMPR Newswire (US)Schools Hub Announces Release of AI-Powered Learning Solution Marketplace for Vocational Training
05/13/202412:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AAONAAON Inc
05/13/202412:09PMBusiness WireFINRA Promotes Michael Solomon to Executive Vice President of Examinations and Membership Application Program
05/13/202412:08PMGlobeNewswire Inc.AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036EU:ABAb Science
05/13/202412:08PMGlobeNewswire Inc.The Minority Business Development Agency to Host 2024 National AANHPI Business Summit at U.S. Department of Commerce
05/13/202412:08PMGlobeNewswire Inc.AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036LSE:0Q77Ab Science Sa
05/13/202412:08PMGlobeNewswire Inc.AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036EU:ABAb Science
05/13/202412:08PMGlobeNewswire Inc.AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036TG:A8DAb Science
05/13/202412:08PMGlobeNewswire Inc.AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036EU:ABAb Science
05/13/202412:08PMGlobeNewswire Inc.AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036LSE:0Q77Ab Science Sa
05/13/202412:08PMGlobeNewswire Inc.AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036TG:A8DAb Science
05/13/202412:08PMPR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - LI.WTTSXV:LIAmerican Lithium Corp
05/13/202412:07PMEdgar (US Regulatory)Form ABS-15G/A - Asset-backed securitizer report pursuant to Section 15G: [Amend]USOTC:FNMFOFederal National Mortgage Association (PK)